Showing results (1291-1300 of 1,318) with videos related to

Sort By:
Pageof 132
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2019
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy responseSai-Lan Liu, Xue-Song Sun, Jin-Jie Yan, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine proteaseRobert B Perni, Susan J Almquist, Randal A Byrn, et al.
The American Journal of Gastroenterology|February 4, 2006
Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progressionMarla C Dubinsky, Ying-Chao Lin, Debra Dutridge, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimizationRobert B Perni, Janos Pitlik, Shawn D Britt, et al.
Therapeutic Advances in Medical Oncology|July 21, 2022
Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective studyMeng-Xia Zhang, Ting Liu, Rui You, et al.
Cell Reports. Medicine|October 16, 2024
A phase 2 trial of gemcitabine plus toripalimab for cisplatin-ineligible patients with recurrent or metastatic nasopharyngeal carcinomaXiong Zou, Xi Ding, Zheng-Kai Feng, et al.
Frontiers in Oncology|July 26, 2021
The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter StudyJason C Hsu, Phung-Anh Nguyen, Yen-Tzu Chen, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Inhibitors of hepatitis C virus NS3.4A protease. Part 3: P2 proline variantsRobert B Perni, Luc J Farmer, Kevin M Cottrell, et al.
European Radiology|January 8, 2021
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control studyBei-Bei Xiao, Qiu-Yan Chen, Xue-Song Sun, et al.
Nature Communications|July 8, 2015
Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association studyPei-Lung Chen, Shyang-Rong Shih, Pei-Wen Wang, et al.
Pageof 132